Some microbes in the guts of humans and mice may help control the buildup of plaque in arteries, the leading cause of cardiovascular disease, by gobbling up a group of inflammatory chemicals before they can circulate in the body.
A new study from Wan-Ju Li’s lab in the UW–Madison Stem Cell & Regenerative Medicine Center advances research into reparative osteoarthritis therapies using stem cells derived from the ears of miniature pigs.
A study by the Center for Healthy Minds at UW–Madison is the first to demonstrate pain-related brain changes from a standardized mindfulness course that is widely offered in clinical settings.
Researchers at the UW School of Veterinary Medicine explain that the bacterium Staphylococcus aureus not only causes illness, but undermines the body’s ability to heal — a finding that could point toward new approaches to fighting infection.
“What we’d hope is that you could counter uncertainty by learning more about the world … (but) that wasn’t the case with COVID-19,” says researcher Markus Brauer. “Higher media consumption — seeking out the news — was associated with more emotional distress.”
Ann Palmenberg, professor of virology and biochemistry, explains how vaccines trick your immune system into thinking you’ve had an infection so you’ll be protected when a real virus comes along.
The heart muscle cells, according to the UW–Madison Stem Cell & Regenerative Medicine Center, could be useful for cardiac repair, regeneration and cell therapy.
A second line of defense — the immune system’s T cells — may offer protection from COVID-19 even when vaccine-induced antibodies no longer can, according to new research out of the University of Wisconsin School of Veterinary Medicine.
It’s likely the foxes contracted the virus after eating or coming into contact with infected birds. Humans remain at low risk for developing HPAI infection, but should refrain from approaching sick or dead wildlife.
Researchers in the UW School of Medicine and Public Health say family rules on the amount of screen time teens are allowed are less effective in fostering good digital practices than focusing on the content of what they are viewing.
Jorge Osorio, an expert in epidemiology, virology and vaccines, has been named the next director of GHI, which applies research, education and outreach to advance equitable and sustainable health in Wisconsin and around the world.
Through the rest of spring semester, UW–Madison will continue to offer free PCR testing, antigen test kits, and surgical and N95 masks to students and employees. Mandatory testing of unvaccinated individuals is paused, effective April 4.
Most human diseases don’t start — or end — with our species. Only by looking at the whole picture can scientists like UW–Madison’s Tony Goldberg uncover the full story of viruses on Earth.
Preventive medicine chief resident Devlin Cole from the UW School of Medicine and Public Health explains why discontinuing masking does not put us at risk of contracting infections that are more severe.
UW–Madison School of Pharmacy students concluded that just 15% of CBD-infused oil, beverages and other products are labeled correctly, based on a survey of stores in Southwestern Wisconsin.
The four recipients of this year’s awards showcase how the university and its alumni are leading innovation in technology and manufacturing, bolstering the local startup ecosystem, and driving economic growth in the state and across the country.
After more than 30 years with UW–Madison and 12 years with the Morgridge Institute for Research, Thomson has announced plans to retire in July.
In findings that surprised researchers, a new study reveals that complexin — a protein long known to play a role in communication between cells in the brain — is also capable of obliterating cells if left unchecked.
UW School of Medicine and Public Health experts Devlin Cole, a preventive medicine resident in the Department of Population Health Sciences, and James Conway, the Pediatric Infectious Diseases Fellowship Program director and Office of Global Health director, provide the answers.
Ketamine has been shown to relieve depression-like symptoms in animal studies. With human volunteers, researchers Sounak Mohanta and Yuri Saalmann concluded that the drug blocks “negative predictions” that are prominent in depressed patients.